Skip to main content
logo
Vista Pharmaceuticals Limited (BOM:524711)
India flag India · Delayed Price · Currency is INR
7.00
-0.12 (-1.69%)
At close: Jul 28, 2026

Vista Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-46.49-45.12-56.62-8.89-20.09
Depreciation & Amortization
7.387.26.186.167.28
Loss (Gain) From Sale of Investments
0.250.04-0.14--0.24
Other Operating Activities
-1.035.5420.63-8.39-1.3
Change in Accounts Receivable
7.37-30.31-7.87-4.0281.11
Change in Inventory
-14.348.9116.513.54-
Change in Accounts Payable
-18.1-3.9724.362.62-43.21
Change in Other Net Operating Assets
-4.888.58-20.16-0.95-91.01
Operating Cash Flow
-69.85-49.14-17.11-9.93-67.47
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Capital Expenditures
-4.4-7.9-12.7-0.14-2.99
Investing Cash Flow
-4.4-7.9-12.7-0.14-2.99

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Short-Term Debt Issued
-7.97---
Long-Term Debt Issued
---6.7431.86
Total Debt Issued
-7.97-6.7431.86
Short-Term Debt Repaid
-0.07--3.46--
Long-Term Debt Repaid
-5.53-22.47-22.47--
Total Debt Repaid
-5.6-22.47-25.92--
Net Debt Issued (Repaid)
-5.6-14.5-25.926.7431.86
Issuance of Common Stock
143.8796.087.63-90
Other Financing Activities
-57.63-25.6449.432.65-52.26
Financing Cash Flow
80.6455.9431.149.3969.61

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Miscellaneous Cash Flow Adjustments
--0-0-0
Net Cash Flow
6.39-1.11.32-0.68-0.85

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Free Cash Flow
-74.25-57.04-29.82-10.07-70.46
Free Cash Flow Growth
-----
Free Cash Flow Margin
-73.70%-55.44%-297.07%-255.34%-556.35%
Free Cash Flow Per Share
-1.26-1.31-0.81-0.27-2.03
Levered Free Cash Flow
-61.172.14-25.52-92.0850.57
Unlevered Free Cash Flow
-55.3379.86-17.34-86.4760.22

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash Interest Paid
9.6412.212.14915.49
Cash Income Tax Paid
4.3--10.53--
Change in Working Capital
-29.95-16.7912.841.19-53.11